CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Purdue Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Imbrium Therapeutics | PURDUE | Purdue Frederick | PURDUE FREDERICK | PURDUE GMP | PURDUE PHARMA | Purdue Pharma, Canada | Purdue Pharma LP | PURDUE PHARMA LP | Purdue Pharma L.P., Stamford, CT

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 1996

First marketed drug

Jun 1, 1959

First NDA

Jun 1, 1959

Last known activity

Oct 14, 2024

Defunct as of Sep 16, 2019

Timeline

1890s

  1. Jan 1, 1892

    Purdue Pharmaceuticals— Founded

1950s

  1. Jun 1, 1959

    phenyl aminosalicylate— NDA Organization

1980s

  1. May 29, 1987

    morphine— NDA Secondary Org

2000s

  1. Sep 24, 2004

    hydromorphone— Marketing Organization

2010s

  1. Oct 22, 2018

    SpineThera, Inc.— Acquired

  2. Sep 16, 2019

    Purdue Pharmaceuticals— Defunct

Drugs by trial phase (33 distinct, 86 trials)

Indications

Approved for

Studied for

Marketed drugs (14)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
New York, NY, US Jan 1, 1892
First NDA
Jun 1, 1959
Last known activity
Oct 14, 2024

Designations held

  • Priority review